Home > Insider Trading > Filing (0001192482-21-000050)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640701	B Alison Fleming	C/O Collegium Pharmaceutical, Inc. 100 Technology Center Drive Stoughton MA 02072	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-01-19	3,336	$5.73	114,755	No	4	M	Direct
Common Stock	Disposition	2018-01-19	3,336	$23.00	111,419	No	4	S	Direct
Common Stock	Acquisiton	2021-01-07	16,042	$5.73	127,461	No	4	M	Direct
Common Stock	Disposition	2021-01-07	16,042	$22.00	111,419	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Purchase)	Disposition	2018-01-19	3,336	$0.00	3,336	$5.73
Common Stock	Stock Option (Right to Purchase)	Disposition	2021-01-07	16,042	$0.00	16,042	$5.73

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,042		2025-03-19	No	4	M	Direct
0		2025-03-19	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 occurring on January 19, 2018 are late due to an administrative error.
The sales occurring on January 19, 2018 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
The sales occurring on January 7, 2021 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020.
At the time of exercise, 3,336 shares under the option were exercisable. The option, initially representing a right to purchase a total of 60,378 shares, vested and became exercisable over a four-year period commencing on March 19, 2015. The option vested and became exercisable in equal installments (rounded up to the nearest whole share) on a monthly basis over a four-year period commencing on March 19, 2015, subject to the employee's continued service with the issuer.
The option was fully vested and exercisable as of January 7, 2021.